Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complementation Tests00:49

Complementation Tests

6.6K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.6K
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

56
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
56
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

586
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
586
Complementary DNA01:44

Complementary DNA

32.4K
Overview
32.4K
Complementary DNA01:44

Complementary DNA

7.3K
7.3K
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

2.5K
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Regulatory Incentive Programs on the Future of Pediatric Drug Development.

Therapeutic innovation & regulatory science·2019
Same author

Are Regulation and Innovation Priorities Serving Public Health Needs?

Frontiers in pharmacology·2019
Same author

Regenerative Medicine at the Forefront of Innovation: Update From Japan.

Clinical therapeutics·2018
Same author

Public- and Private-Sector Contributions to the Research and Development of the Most Transformational Drugs in the Past 25 Years: From Theory to Therapy.

Therapeutic innovation & regulatory science·2018
Same author

Prospects for Harmonizing Regulatory Science Programs in Europe, Japan, and the United States to Advance Regenerative Medicine.

Therapeutic innovation & regulatory science·2018
Same author

Challenge and Change at the Forefront of Regenerative Medicine.

Clinical therapeutics·2018

Related Experiment Video

Updated: Apr 18, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

14.2K

Complementary versus companion diagnostics: apples and oranges?

Christopher-Paul Milne1, Crystal Bryan, Steven Garafalo

  • 1Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine, Boston, MA 02111, USA.

Biomarkers in Medicine
|January 22, 2015
PubMed
Summary

Precision medicine advances face challenges from drug efficacy issues and competition. Personalized treatments, using pharmacogenomic biomarkers, are evolving, but companion and complementary diagnostics present distinct economic and regulatory paths.

Keywords:
companion diagnosticscomplementary diagnosticslate-stage pipeline analysispartnering landscapepersonalized medicine

More Related Videos

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

4.7K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.8K

Related Experiment Videos

Last Updated: Apr 18, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
08:23

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

14.2K
Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

4.7K
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.8K

Area of Science:

  • Biopharmaceutical Development
  • Genomics and Personalized Medicine
  • Regulatory Science

Background:

  • Biopharmaceutical development since the late 1990s faces significant challenges, including drug efficacy and market competition.
  • The US FDA recognizes the shift from one-size-fits-all treatments towards personalized medicine, driven by biomarker advancements.
  • Over 11,000 biomarkers are tracked in commercial databases, facilitating personalized approaches.

Purpose of the Study:

  • To examine the divergence in personalized medicine trajectories.
  • To analyze the differentiation between companion and complementary diagnostics.
  • To explore the economic, regulatory, and strategic ramifications of these diagnostic approaches.

Main Methods:

  • Review of current trends in biopharmaceutical development and personalized medicine.
  • Analysis of the characteristics and applications of companion diagnostics.
  • Analysis of the characteristics and applications of complementary diagnostics.

Main Results:

  • Personalized medicine is a natural outcome of advances in biomarkers and genomics.
  • Companion diagnostics are drug-specific and labeled for particular uses.
  • Complementary diagnostics are broadly associated with drug classes, not specific drugs or uses.

Conclusions:

  • A divergence exists in personalized medicine approaches based on diagnostic types.
  • Companion and complementary diagnostics have distinct economic, regulatory, and strategic implications.
  • Understanding these differences is crucial for the biopharmaceutical industry's innovation trajectory.